Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACTA phase III trial in HIV-associated cryptococcal meningitis
ISRCTN45035509Phase 3Completed
- Sponsor
- St George's, University of London
- Start
- Jan 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
01
Overview
Phase 3, randomised, open-label trial of fluconazole, flucytosine and amphotericin b in cryptococcal meningitis (5 arms), sponsored by St George's, University of London. Primary endpoint: Mortality at 2 weeks. Started Jan 2013; status: completed.
02
Drugs
fluconazoleflucytosineamphotericin b
03
Conditions
cryptococcal meningitis
Beyond the preview
Go deeper on ISRCTN45035509.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN45035509.